Global Sinusitis Drugs Market 2019-2023| 6% CAGR Projection Over the Next Five Years | Technavio

LONDON–(BUSINESS WIRE)–#HealthCare–The global sinusitis drugs market is expected to post a CAGR of over 6%
during the period 2019-2023, according to the latest market research
report by Technavio.

A key factor driving the growth of the global sinusitis drugs market is
the rise in the prevalence of sinusitis. Sinus infection is caused due
to the fluid entrapment in the sinus glands, eventually inducing the
propagation of germs in these glands. Allergies, pollutants, and fungal
infections are vital factors responsible for the rising incidence of
sinusitis. This has led to the need to develop and manufacture sinusitis
drugs among the several stakeholders of the healthcare industry. Growing
awareness about the symptoms of the disease is propelling an early
diagnosis resulting in better clinical outcomes. This will foster the
growth of the sinusitis drugs market during the forecast period.

As per Technavio, the advent of biologics will have a positive impact on
the market and contribute to its growth significantly over the forecast
period. This global
sinusitis drugs market 2019-2023 research report also
analyzes other significant trends and market drivers that will affect
market growth over 2019-2023.

Global sinusitis drugs market: Advent of
biologics

The emergence of biologics is one of the critical trends gaining
traction in the sinusitis drugs market. Among the biologics that are
currently being evaluated, omalizumab has evolved as the most suitable
candidate. Omalizumab, a recombinant humanized monoclonal antibody, has
been approved for the treatment of severe allergic asthma in the US and
Europe. Scientists are evaluating Omalizumab on the parameters of safety
and efficacy for the treatment of chronic rhinosinusitis with nasal
polyps. Successful launch of biologics such as omalizumab is likely to
drive the sinusitis drugs market growth in the forthcoming years.

“The sinusitis drugs market is witnessing rising investments in the
R&D by several market participants to develop novel drugs for the
treatment of this chronic condition. Thus, the increasing investments
coupled with the emergence of novel drug delivery systems is expected to
ensure increased volume consumption of the sinusitis drugs market during
the forecast period,” says a senior research analyst at Technavio.

Global sinusitis drugs market: Segmentation
analysis

This market research report segments the global sinusitis drugs market
by product (steroid nasal sprays, antibiotics, decongestants, and other
drugs) and geographic regions (North America, Europe, Asia, and ROW).

North America led the market in 2018, followed by Europe, Asia, and ROW,
respectively. The market growth in North America can be attributed to
the increased investments in R&D by large pharmaceutical companies and
the presence of a proper regulatory framework for the approval of new
drugs in the region.

Looking for more information on this market? Request
a free sample report

Technavio’s sample reports are free of charge and contain multiple
sections of the report, such as the market size and forecast, drivers,
challenges, trends, and more.

Some of the key topics covered in the report include:

Market Landscape

• Market ecosystem
• Market characteristics
• Market segmentation analysis

Market Sizing

• Market definition
• Market size and forecast

Five Forces Analysis

Market Segmentation

Geographical Segmentation

• Regional comparison
• Key leading countries

Market Drivers

Market Challenges

Market Trends

Vendor Landscape

• Vendors covered
• Vendor classification
• Market positioning of vendors
• Competitive scenario

About Technavio

Technavio
is a leading global technology research and advisory company. Their
research and analysis focuses on emerging market trends and provides
actionable insights to help businesses identify market opportunities and
develop effective strategies to optimize their market positions.

With over 500 specialized analysts, Technavio’s report library consists
of more than 10,000 reports and counting, covering 800 technologies,
spanning across 50 countries. Their client base consists of enterprises
of all sizes, including more than 100 Fortune 500 companies. This
growing client base relies on Technavio’s comprehensive coverage,
extensive research, and actionable market insights to identify
opportunities in existing and potential markets and assess their
competitive positions within changing market scenarios.

If you are interested in more information, please contact our media team
at [email protected].

Contacts

Technavio Research
Jesse Maida
Media & Marketing Executive
US:
+1 844 364 1100
UK: +44 203 893 3200
www.technavio.com